Similar articles

• Craniopharyngioma in a mother and daughter.

  Green AL, Yeh JS, Dias PS. Green AL, et al. Acta Neurochir (Wien). 2002 Apr;144(4):403-4. doi: 10.1007/s007010200058. Acta Neurochir (Wien). 2002. PMID: 12021891 No abstract available.
• Pronounced response of papillary craniopharyngioma to treatment with vemurafenib, a BRAF inhibitor.

  Aylwin SJ, Bodi I, Beaney R. Aylwin SJ, et al. Pituitary. 2016 Oct;19(5):544-6. doi: 10.1007/s11102-015-0663-4. Pituitary. 2016. PMID: 26115708 Free PMC article. No abstract available.
• Diseases of the pituitary.

  Asa SL. Asa SL. Neurosurg Clin N Am. 1994 Jan;5(1):71-95. Neurosurg Clin N Am. 1994. PMID: 8124095 Review.
• Lack of chromosomal imbalances in adamantinomatous and papillary craniopharyngiomas.

  Rickert CH, Paulus W. Rickert CH, et al. J Neurol Neurosurg Psychiatry. 2003 Feb;74(2):260-1. doi: 10.1136/jnnp.74.2.260. J Neurol Neurosurg Psychiatry. 2003. PMID: 12531965 Free PMC article.
• 60 YEARS OF NEUROENDOCRINOLOGY: Biology of human craniopharyngioma: lessons from mouse models.

  Martinez-Barbera JP. Martinez-Barbera JP. J Endocrinol. 2015 Aug;226(2):T161-72. doi: 10.1530/JOE-15-0145. Epub 2015 Apr 29. J Endocrinol. 2015. PMID: 25926515 Review.